605033.SS Stock Analysis
60
Uncovered
Shaanxi Meibang Pharmaceutical Group Co Ltd is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Moderate score
Shaanxi Meibang Pharmaceutical Group Co., Ltd. engages in the research, development, production, and sale of pesticide preparations. The company is headquartered in Xi'An, Shaanxi and currently employs 933 full-time employees. The company went IPO on 2021-09-16. The firm's products mainly include fungicides and pesticides. The fungicides include 80% dimethylmorpholine water dispersible granules, 27% chunleimycin bromonitrile wettable powder, 72% pyrazole ether ester combined water dispersible granules, 22% chunleimycin chlorobromoisocyanuric acid wettable powder, etc. The insecticides include 21% abamectin benzoate fenitrile suspension, 22% thiamethoxam beta cypermethrin suspension, 45% biphenyl hydrazide ethiconazole suspension, 20% fenitrile bifenthrin suspension, etc.